Vitrafy Life Sciences Ltd (ASX:VFY – Get Free Report) insider John McBain bought 28,255 shares of the stock in a transaction dated Tuesday, March 18th. The stock was purchased at an average cost of A$1.36 ($0.86) per share, with a total value of A$38,426.80 ($24,167.80).
Vitrafy Life Sciences Price Performance
Featured Articles
- Five stocks we like better than Vitrafy Life Sciences
- Short Selling – The Pros and Cons
- Analysts Are Upgrading These 5 Software Stocks—Should You Buy?
- Investing in Travel Stocks Benefits
- 3 ETFs Every Investor Needs to Hedge S&P 500 Volatility
- Most Volatile Stocks, What Investors Need to Know
- 4 Undervalued Growth Stocks to Buy and Hold for the Long Term
Receive News & Ratings for Vitrafy Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrafy Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
